Abbott 装置 helps in cutting 血 sugar in type 2 diabetics - 熟考する／考慮する (June 8)
By Saumya Joseph
June 8 (Reuters) - Insulin-扶養家族 患者s with type 2 糖尿病 saw a 重要な 減少（する） in their 血 sugar levels after wearing Abbott 研究室／実験室s Inc's continuous glucose 監視するing system for three months compared with when they were not using the 装置, 研究員s said on Saturday.
The 熟考する／考慮する, which was 現在のd at the American 糖尿病 協会 会合 in San Francisco, 査定する／（税金などを）課すd the 医療の 記録，記録的な／記録するs of 363 type 2 diabetics in フラン, Germany and Austria between three and six months.
Dr. Helene Hanaire of the University Hospital 中心 of Toulouse, フラン, one of the 熟考する／考慮する authors, said having ready 接近 to their 血 glucose readings helped diabetics become more engaged with controlling their glucose levels.
患者s in the 熟考する／考慮する, whose 普通の／平均（する） age was 63, used 多重の insulin 注射s every day over an 普通の／平均（する） of more than eight years.
An 分析 of 患者 記録，記録的な／記録するs 設立する that 患者s who used Abbott's FreeStyle Libre - a 装置 worn on the 団体／死体 that 監視するs 血 sugar continuously through a sensor under the 肌 - helped 患者s 減ずる hemoglobin A1c by nearly 1%.
Hemoglobin A1c levels is a 手段 of a person's 普通の／平均（する） 血 sugar for three months and 示すs the 危険 for developing long-称する，呼ぶ／期間／用語 複雑化s from 糖尿病.
患者s who used the 装置 for at least three months saw their A1c levels 減少（する） to an 普通の／平均（する） of 8%, from the previous level of 8.9%, when they did not use the 装置. However, this was still above the American 糖尿病 協会's recommended 的 of 7%.
Type 2 糖尿病 is the most ありふれた form of 糖尿病, and many 患者s can keep their 血 sugar within the recommended 範囲 with oral 医薬s and do not need insulin. However, those on insulin 要求する 正規の／正選手 監視するing of 血 sugar levels.
Abbott's FreeStyle Libre, which can be worn for up to 14 days, 減ずるs the need for the 伝統的な fingerstick 実験（する）ing.
(Repo rting by Saumya Sibi Joseph in Bengaluru; Editing by James Emmanuel)
